Malaria

dc.contributor.authorAdanu, R.M.
dc.date.accessioned2018-10-25T12:17:31Z
dc.date.available2018-10-25T12:17:31Z
dc.date.issued2015
dc.description.abstractMalaria is a parasitic infestation caused by the protozoa Plasmodium, which is transmitted through the bite of the female anopheles mosquito. Pregnancy results in reduction in cell-mediated immunity. This decreased immunity makes pregnant women more susceptible to malaria than non-pregnant women. The treatment of malaria in pregnancy is determined by the stage of pregnancy at which the disease is diagnosed. In holoendemic areas, artemisin-based combination therapy (ACT) is recommended as the standard preferred treatment to improve efficacy and limit drug resistance. Intermitted preventive treatment in pregnancy is the use of anti-malarial medications at defined intervals during the pregnancy regardless of the presence or absence of confirmed malaria. It is recommended that pregnant women in holoendemic areas sleep under insecticide-treated bed-nets in order to reduce the frequency of mosquito bites during pregnancy. Effective diagnosis and treatment of malaria helps prevent the occurrence of maternal and fetal complications of malaria. © 2015 by John Wiley & Sons, Ltd. All rights reserved.en_US
dc.identifier.other10.1002/9781119001256.ch28
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/24823
dc.language.isoenen_US
dc.publisherProtocols for High-Risk Pregnancies: An Evidence-Based Approach: Sixth Editionen_US
dc.subjectArtemisin-based combination therapyen_US
dc.subjectCell-mediated immunityen_US
dc.subjectFemale anopheles mosquitoen_US
dc.subjectFetal complicationen_US
dc.subjectHoloendemic areasen_US
dc.subjectInsecticide-treated bed-netsen_US
dc.subjectIntermitted preventive treatmenten_US
dc.subjectMalariaen_US
dc.subjectMaternal complicationen_US
dc.subjectParasitic infestationen_US
dc.titleMalariaen_US
dc.typeBook chapteren_US

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: